NoBsRx review
Every program is named low-dose, and all three twelve-week blocks cost the same regardless of molecule.
The verdict
NoBsRx publishes $140 a month for injectable semaglutide, $179 for the oral and $140 for injectable tirzepatide, read September 2026. Each program is labeled low-dose. All three twelve-week blocks are $409.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 telehealth
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection · Oral
- Dose pricing
- Flat across doses
- Injection
- From $179/mo
- Oral
- From $199/mo
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
NoBsRx sells both molecules, injected and oral, as named low-dose programs. Three lines carry a monthly figure. Each also carries a twelve-week price, and those are identical across the three.
Who writes the prescription, and what do they see?
A prescription precedes dispensing. The pages name the program rather than the clinician. What the intake asks is not published. The dose framing is stated, which is the rarer disclosure of the two.
Calling the programs low-dose on the product itself is the notable act. It stops the rate reading as a standard starting dose. NoBsRx states the rate holds at every dose, which on a low-dose program is the claim worth confirming at intake.
What happens when the dose goes up?
The rate is stated to hold. The programs are low-dose by name. A buyer moving to standard dosing is not covered by anything published. The pages do not say whether that move exists.
What the price includes
$140 a month is the injectable figure on both molecules, which removes the usual tirzepatide premium entirely. The oral runs $179. The twelve-week block is $409 whichever program is chosen, so the block is priced by term rather than by molecule. That is an unusual structure and it is published rather than inferred.
What it claims, and what it cites
Every line is compounded. None is FDA-approved. No agency reviews them before dispensing. A low-dose program is a smaller quantity of the same molecule, not a different one.
Where it holds up, and where it does not
- Strength: Every program is labeled low-dose
- Strength: Tirzepatide carries no premium here
- Strength: The twelve-week price is published too
- Limitation: All programs are low-dose only
- Limitation: No milligram figure is published
- Limitation: Standard dosing is not addressed
- Limitation: No state coverage list is recorded
What the evidence says about this kind of treatment
The assessment above is about NoBsRx. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- A reader who wants a low-dose program named as one and priced the same either molecule.
- Wrong for
- A reader who expects to move to a standard dose.
How NoBsRx compares
| Seller | Who it suits | Go |
|---|---|---|
| Zera Health | A reader who reads the dose qualifier before the figure, since the $129 line is described as low-dose rather than as the standing rate. | See Zera Health → |
| Bayan Health | A reader weighing an injection against an oral preparation at one seller, where both routes carry the same monthly figure. | See Bayan Health → |
| Good Girl Rx | Readers deliberately starting at a microdose and comparing on that basis | See Good Girl Rx → |
More GLP-1 telehealth sellers reviews: Direct MedsDoctorAdamDrBrainRxDreamHug MedicalDudeMedsEdgeRx
Sponsored alternative
Synergy Rx
A reader who wants the oral and injectable rates for both molecules stated up front rather than after an intake form.
Check Synergy Rx availability →Frequently asked
- Why does tirzepatide cost the same as semaglutide?
- NoBsRx prices both injectable programs at $140 a month. Most sellers charge a premium for tirzepatide; this one does not.
- What is a low-dose program?
- A smaller quantity of the same molecule. NoBsRx names all three programs that way rather than leaving the rate to read as a standard dose.
- Is twelve weeks cheaper?
- It is $409 on every program. That sits below three months of the oral at its monthly rate, and above three months of either injection.
- Is NoBsRx expensive compared with other GLP-1 telehealth sellers?
- NoBsRx publishes a starting figure of $179/mo. Across the 83 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $76 to $299 with a median of $179, which puts NoBsRx right at the median. The other 5 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.